Log in to search using one of your social media accounts:

 

STPs to buy consultancy and tech from 'one stop shop'
NHS England is developing a new “one stop shop” framework for local health systems to buy products and services ranging from workforce advice to IT systems. (Source: HSJ)
Source: HSJ - November 16, 2017 Category: UK Health Source Type: news

Doing the double: Pegasus is crowned PRCA ’s ‘specialist consultancy’ for the second year
Held at London’s Park Lane Hilton (Tuesday 7th November), the PRCA National Awards honour the best of the UK PR and communications industries. Pegasus, an Ashfield Healthcare Communications’ agency, battled it out against five other agencies to win the prestigious award. Judges were impressed with the way Pegasus drives its mission of ‘inspiring healthy decisions’  right through the business – from award-winning campaigns for some of the world’s most influential health organisations, to staff perks such as flexible working hours, daily fresh fruit and in-office massages. Pegasus Man...
Source: Ashfield Healthcare News - November 15, 2017 Category: Pharmaceuticals Authors: Alanna Simpkin Tags: Ashfield Source Type: news

CCGs spend millions on consultancy for stalled reconfiguration
Commissioners in north west London spent £36m on consultancy firms over the last four financial years – including millions on service redesign recently stalled by NHS Improvement. (Source: HSJ)
Source: HSJ - November 15, 2017 Category: UK Health Source Type: news

Exclusive: NHSI condemns trust's 'significant' financial governance failings
A confidential report into a large acute trust has uncovered ‘significant’ financial governance failings over how it agreed its control total for this year, alongside irregularities in its consultancy spend, contracting and use of interim managers. (Source: HSJ)
Source: HSJ - November 10, 2017 Category: UK Health Source Type: news

Ashfield Pharmacovigilance to sponsor Proventa Internationals ’ B2B Pharmacovigilance Strategy Meeting USA 2017
Ashfield Pharmacovigilance, part of UDG Healthcare, is proud to sponsor Proventa International’s B2B Pharmacovigilance Strategy Meeting USA 2017, which will take place November 7, 2017 in Boston Massachusetts at The Westin Boston Waterfront. This event gathers leading pharmacovigilance experts from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve key strategic challenges in the area of Pharmacovigilance. Proventa International is a Management and Market Intelligence Consultancy specializing in life sciences and healthcare sectors. By creating an executive net...
Source: Ashfield Healthcare News - October 30, 2017 Category: Pharmaceuticals Authors: Alanna Simpkin Tags: Ashfield Source Type: news

MSLs: The Superheroes of Pharma?
The Medical Science Liaison (MSL) has come a long way in a short time. While pharma never stands still for long, the need for scientifically credible partners to help customers understand the growing complexity of new medicines and navigate the choppy waters of real-world evidence and health outcomes, has seen the MSL come to the fore in ways few might have imagined.While the core competencies of the MSL remain unchanged, new capabilities will be needed – both for MSLs and MSL leaders – to meet the demands of the changing roles. But what does the modern MSL look like and what skills will they need now and in th...
Source: EyeForPharma - October 25, 2017 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news

Digital Diabetes Care Getting Simpler for Patients
Diabetes is one of the most expensive chronic health conditions worldwide, and has become a favorite target of leading-edge clinicians and technologists touting the age of connected care. "In general, we'll see more of the trend of digitalization to better manage conditions," said Chuck Gammal, a partner specializing in healthcare and medical technology at consultancy Simon-Kucher. "Diabetes is somewhat unique among chronic conditions in that it's very data-intensive." Ironically, though the very data-intensive nature of diabetes care might suggest patients would clamor for platforms and care modules th...
Source: MDDI - October 20, 2017 Category: Medical Devices Authors: Greg Goth Tags: R & D Source Type: news

Exclusive: Consultancy firm avoids prosecution over use of restricted NHS data
A large consultancy firm has escaped prosecution over the use of restricted NHS data to win contracts, HSJ can reveal. (Source: HSJ)
Source: HSJ - October 19, 2017 Category: UK Health Source Type: news

Mauritius: New Cancer Centre to Be Constructed in Vacoas, Announces Minister Husnoo
[Government of Mauritius] The Ministry of Health and Quality of Life will proceed with the construction of a new state-of-the-art cancer centre in Vacoas with the collaboration of the Hospital Service Consultancy Corporation (HSCC) Limited from India. Under mutual government agreement between India and Mauritius, the HSCC will assist the Ministry of Health and Quality of Life as consultant. The construction of the new cancer centre is expected to start early in 2018 and will be completed in about 15 months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 6, 2017 Category: African Health Source Type: news

Philanthropists Join Forces to Fund Africa ’s Cash-Strapped Health Sector
Tristate Heart and Vascular Centre in Nigeria. Credit: Tristate Heart and Vascular CentreBy Pavithra Rao, Africa Renewal*NEW YORK, Sep 28 2017 (IPS)In the 2017 World Happiness Report by Gallup, African countries score poorly. Of the 150 countries on the list, the Central African Republic, Tanzania and Burundi rank as the unhappiest countries in the world. Some of the factors driving unhappiness are the poor state of the continent’s health care systems, the persistence of HIV/AIDS, malaria and tuberculosis, and the growth of lifestyle diseases such as hypertension, heart disease and diabetes.Few African countries make...
Source: IPS Inter Press Service - Health - September 28, 2017 Category: International Medicine & Public Health Authors: Pavithra Rao Tags: Development & Aid Featured Global Headlines Health TerraViva United Nations Source Type: news

Pharmabide Pharmaceutical Services-Clinical Research and Development Services and Pharmaceutical Market Licensing
Pharmabide Pharmaceutical Services is a consultancy firm for clinical trials, regulatory affairs, and pharmacovigilance. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

New report indicates more doctors now open to integrative medicine
(Natural News) A survey carried out by the consultancy firm Pure Branding revealed that an increasing number of doctors have started incorporating integrative medicine into their practice, which in turn may prove beneficial to the supplements industry. The survey, called Integrative Physicians Market Landscape, examined more than 1,000 integrative doctors from 49 states. Data were obtained from... (Source: NaturalNews.com)
Source: NaturalNews.com - September 21, 2017 Category: Consumer Health News Source Type: news

Exclusive: Sir Mike Richards joins health consultancy
Professor Sir Mike Richards, the previous chief inspector of hospitals, is to take up a new role at a leading health consultancy, it has been announced today. (Source: HSJ)
Source: HSJ - September 20, 2017 Category: UK Health Source Type: news

Q & amp;A: How to Control Development Costs for Implantables
When it comes to implantable devices, the material makeup of the technology is not only critical to the success of the device, but it also has a significant impact on the cost. Often times implantables need to be able to survive some of the harshest conditions in the body, where any kind of unexpected breakdown in materials can have critical adverse effects if they aren’t safely designed. This, of course, leaves many device makers with a very short list of potential materials. Len Czuba is president of Czuba Enterprises, a Chicago, IL-based medical device development consultancy that specializes in helping manufactur...
Source: MDDI - September 20, 2017 Category: Medical Devices Authors: Kristopher Sturgis Tags: MD & M Minneapolis Implants Materials Source Type: news

Costly Drugs to Weigh on U.S. Employers' Expenses in 2018 - Survey Costly Drugs to Weigh on U.S. Employers' Expenses in 2018 - Survey
U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7%, according to consultancy firm Mercer.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Costly drugs to weigh on U.S. employers' expenses in 2018: survey
(Reuters) - U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer. (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Tony Pinsonault Launches ArtSci Health Solutions
Tony Pinsonault launches ArtScī Health Solutions. ArtScī is a healthcare consultancy that provides access to leading market access knowledge experts.(PRWeb September 12, 2017)Read the full story at http://www.prweb.com/releases/health/artsci/prweb14676830.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 12, 2017 Category: Pharmaceuticals Source Type: news

As Hurricane Irma Lashes Florida, an Expert Explains How Cities Can Boost Their Flood Defenses
After it had raged through the Caribbean, sucked the sea back from the Bahamas coast and devastated the tiny island of Barbuda, Hurricane Irma tore up the Florida panhandle Sunday night cutting power for four million people en route to Tampa. A map produced by the U.S. National Hurricane Center showed that along parts of the State’s southwestern coast storm surge flooding could surpass nine feet; already, parts of downtown Miami were a couple of feet underwater. “Pray for us,” Florida governor Rick Scott said in an interview as the hurricane began its assault on his state. Meanwhile, a thousand miles wes...
Source: TIME.com: Top Science and Health Stories - September 11, 2017 Category: Consumer Health News Authors: Joseph Hincks / Hong Kong Tags: Uncategorized Floods Florida onetime weather Source Type: news

Clinipace lands former Quintiles exec for its board
Morrisville-based clinical research organization Clinipace Worldwide has added Steve Skolsky, former senior vice president and managing director at Quintiles, to its board of directors. Prior to his tenure (2011 to 2016) at Quintiles – which merged with IMS Health last year to form QuintilesIMS – Skolsky served as CEO of both Trimeris and Sequoia Pharmaceuticals, and spent two decades at GlaxoSmithKline. He currently serves as principal of life science consultancy Expis Part ners. “I look… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 5, 2017 Category: American Health Authors: Jennifer Henderson Source Type: news

San Francisco private equity firm snaps up part of D.C. consultancy in $2.6 billion deal
D.C.-based consultancy The Advisory Board Co. (NASDAQ: ABCO) has reached agreements to sell its health care and education businesses in a deal valued at $2.58 billion to San Francisco-based private equity firm Vista Equity Partners. Under a complex arrangement, Vista will acquire the education business for $1.55 billion, while Eden Prairie, Minnesota-based Optum will take the health care business in a $1.3 billion merger, which includes the assumption of debt. Trending: These Bay Area school districts… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 29, 2017 Category: Pharmaceuticals Authors: Drew Hansen Source Type: news

Advisory Board reaches $2.58B deal to sell education, health care businesses
D.C.-based consultancy The Advisory Board Co. (NASDAQ: ABCO) has reached agreements to sell its health care and education businesses in a deal valued at $2.58 billion. Under a complex arrangement, San Francisco-based private equity firm Vista Equity Partners will acquire the education business for $1.55 billion, while Eden Prairie, Minnesota-based Optum will take the health care business in a $1.3 billion merger. It's not clear whether this means the absolute e nd of Advisory Board — we expect… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 29, 2017 Category: American Health Authors: Drew Hansen Source Type: news

Employer Plans Join Obamacare In Narrowing Doctor Networks For 2018
Half of U.S. employers are considering " high performance networks over the next three-to-five years, ” benefits consultancy Aon says (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 27, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:CNC NYSE:AON NYSE:MOH Source Type: news

Trio of hires signal Pegasus ’ northern grit
Growth trend continues at ‘health first, sector second’ agency Pegasus, an Ashfield company, part of UDG Healthcare plc, has announced further growth of its Pharma and Life Sciences division with the appointment of three new team members to its northern base in Macclesfield. Kesha Tansey, Account Director, joins from within Ashfield. Formerly of Zoetic Science and GCC, she will lead integrated communications programmes with teams situated in both Macclesfield and at Pegasus’ Brighton HQ. She is joined by newly appointed Senior Account Executive, Trystan George, who moves from The Scott Partnership and Bi...
Source: Ashfield Healthcare News - August 16, 2017 Category: Pharmaceuticals Authors: Alanna Simpkin Tags: Ashfield Source Type: news

Advisory Board CEO: It's 'business as usual, as much as possible'
Before The Advisory Board Co. (NASDAQ: ABCO) even began its second-quarter conference call Tuesday, CEO Robert Musslewhite warned analysts he wouldn't be answering questions about the one thing they likely wanted to ask about the most: the company's ongoing review of a possible sale. Musslewhite did, however, agree to very briefly answer a question about how that process has been impacting business at the D.C. health care and education consultancy. His message: It's "business as usual, as much as… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 9, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Advisory Board CEO: It's 'business as usual, as much as possible'
Before The Advisory Board Co. (NASDAQ: ABCO) even began its second-quarter conference call Tuesday, CEO Robert Musslewhite warned analysts he wouldn't be answering questions about the one thing they likely wanted to ask about the most: the company's ongoing review of a possible sale. Musslewhite did, however, agree to very briefly answer a question about how that process has been impacting business at the D.C. health care and education consultancy. His message: It's "business as usual, as much as… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Evolent Health stock falls as it proposes yet another public offering
Shares for Arlington-based health consultancy Evolent Health Inc. plummeted Tuesday after the company announced it is looking to raise $175 million through a proposed public offering — the fourth such offering this year. Evolent officials also said they plan to grant underwriters a 30-day option to purchase an additional $26.25 million of its Class A common stock in connection with the proposed public offering. J.P. Morgan Securities LLC and Goldman Sachs& Co. LLC are acting as joint book-running … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Guest Post: Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from Professor Meir Pugatch, IPKM Professor of Valorisation, Entrepreneurship and Management at the University of Maastricht and Managing D...
Source: The Catalyst - July 24, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Economic Impact Intellectual Property Policy Solutions Source Type: news

MP calls for debate on 'revolving door of failed NHS managers'
An MP has called for a debate on “the revolving door of failed NHS managers” after claiming a former trust chief had set up a consultancy firm “offering his services to the NHS”. (Source: HSJ)
Source: HSJ - July 13, 2017 Category: UK Health Source Type: news

Vynamic join Ashfield
Vynamic is headquartered in Philadelphia and its primary service offerings include: brand strategy, planning and launch, advanced commercial operations capabilities, strategic transformation and integration, product design and implementation, change leadership and business intelligence and analytics. The acquisition of Vynamic is in line with Ashfield’s strategy to expand its advisory services to the healthcare industry and follows the acquisition of STEM in October 2016. It is the Group’s first management consultancy acquisition and offers services which are highly complementary to the existing range of servic...
Source: Ashfield Healthcare News - July 12, 2017 Category: Pharmaceuticals Authors: Josee Leach Tags: Ashfield Source Type: news

GE Healthcare  buys Novia Strategies to expand clinical consulting services
GE Healthcare said it is expanding its healthcare consulting business with the acquisition of Novia Strategies, one of the nation ’s oldest clinician-owned and -led healthcare consultancies. Terms of the deal weren’t disclosed. GE Healthcare (NYSE: GE) said the acquisition will expand its ability to help healthcare organizations meet the demand for increased access, enhanced quality and more affordable healthcare for the ir patients. Poway, California-based Novia Strategies, which was founded… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 11, 2017 Category: American Health Authors: I-Chun Chen Source Type: news

GE Healthcare  buys Novia Strategies to expand clinical consulting services
GE Healthcare said it is expanding its healthcare consulting business with the acquisition of Novia Strategies, one of the nation ’s oldest clinician-owned and -led healthcare consultancies. Terms of the deal weren’t disclosed. GE Healthcare (NYSE: GE) said the acquisition will expand its ability to help healthcare organizations meet the demand for increased access, enhanced quality and more affordable healthcare for the ir patients. Poway, California-based Novia Strategies, which was founded… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 11, 2017 Category: Biotechnology Authors: I-Chun Chen Source Type: news

EQT to acquire pharmaceutical services firm Certara
(Reuters) - Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm. (Source: Reuters: Health)
Source: Reuters: Health - July 11, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

EQT nears deal to acquire pharma services firm Certara: sources
(Reuters) - Private equity firm EQT is nearing a deal to acquire U.S. drug development consultancy Certara for around $850 million, including debt, from Arsenal Capital Partners, another buyout firm, people familiar with the matter said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - July 11, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Revealed: Consultancy paid up to £20m to set up new NHS procurement body
A consultancy firm will be paid up to £20m to help set up the body managing the new NHS procurement model, HSJ can reveal. (Source: HSJ)
Source: HSJ - July 4, 2017 Category: UK Health Source Type: news

Video: A Conversation On Leadership with Jon Harrison
Arkansas Business' "Foundations" interview series continues with Jon Harrison, owner of VIP2 of Little Rock, a consultancy that helps businesses and other organizations through leadership training programs for staff at all levels. In this episode, Harrison talks about the capability to be a good leader, how to handle workplace conflicts, and the philosophy behind developing "values-driven, informed and passionate people" in the workplace. The "Foundations" series aims to highlight key tools for success for businesses, nonprofits and other organizations. The first four videos of the series focu...
Source: Arkansas Business - Health Care - June 21, 2017 Category: American Health Source Type: news

New £250,000 leadership programme for charities launched
21 June 2017The King’s Fund, Comic Relief, and the Big Lottery Fund have opened the application process for a unique support programme enabling charity leaders to help each other through sharing expertise and developing skills.Following a successful pilot, The King’s Fund, Comic Relief and the Big Lottery Fund have agreed to support the roll-out of theCascading Leadership programme so that more charities can benefit. The Big Lottery Fund is investing£175,000 of National Lottery funding alongside£75,000 from Comic Relief.Cascading Leadership was piloted by The King’s Fund and Comic Relief in 20...
Source: The King's Fund - Press - June 20, 2017 Category: UK Health Source Type: news

This former marketing exec is disrupting McKinsey and PwC with 'the Uber of consultancies'
The Gig Economy encapsulates a wide variety of workers. On one end, there's Airbnb and Uber. If you're someone trying to make extra money, startups of a certain ilk can be lucrative. But there's a higher end, too. They could be a seasoned manager or former consultant who ditched the large corporation and went into business for themselves. Gregg Fisher, a former marketing executive, noticed this trend and founded The Stem, a staffing network consisting of hundreds of experts l ooking to lend the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 8, 2017 Category: American Health Authors: Anthony Noto Source Type: news

Improving Care & Response in Nigeria
The journey of EMS care in Nigeria has been a long and challenging one. Before 1995, ambulances in Nigeria were known for undertakers' services and not for carrying live patients.1 That year an oil company operating in the Niger Delta area of Nigeria kicked off a rudimentary ambulance system by engaging an ambulance for rescue and conveying of their emergency staff to the hospital. In the early 90s, Tokaro Emergency Medical Services, a division of an Israeli business group, introduced EMS in Lagos State. Due to low patronage and failed attempts to train some doctors in prehospital care, Tokaro EMS was disbanded a few years...
Source: JEMS Patient Care - May 31, 2017 Category: Emergency Medicine Authors: Nnamdi Nwauwa, EMT, CCEMTP, MBBS, MPH, MMSCEM Tags: Ambulances & Vehicle Ops Cardiac Resuscitation Communications Dispatch Source Type: news

Improving Care & Response in Nigeria
The journey of EMS care in Nigeria has been a long and challenging one. Before 1995, ambulances in Nigeria were known for undertakers' services and not for carrying live patients.1 That year an oil company operating in the Niger Delta area of Nigeria kicked off a rudimentary ambulance system by engaging an ambulance for rescue and conveying of their emergency staff to the hospital. In the early 90s, Tokaro Emergency Medical Services, a division of an Israeli business group, introduced EMS in Lagos State. Due to low patronage and failed attempts to train some doctors in prehospital care, Tokaro EMS was disbanded a few years...
Source: JEMS Administration and Leadership - May 31, 2017 Category: Emergency Medicine Authors: Nnamdi Nwauwa, EMT, CCEMTP, MBBS, MPH, MMSCEM Tags: Ambulances & Vehicle Ops Cardiac Resuscitation Communications Dispatch Source Type: news

Improving Care & Response in Nigeria
The journey of EMS care in Nigeria has been a long and challenging one. Before 1995, ambulances in Nigeria were known for undertakers' services and not for carrying live patients.1 That year an oil company operating in the Niger Delta area of Nigeria kicked off a rudimentary ambulance system by engaging an ambulance for rescue and conveying of their emergency staff to the hospital. In the early 90s, Tokaro Emergency Medical Services, a division of an Israeli business group, introduced EMS in Lagos State. Due to low patronage and failed attempts to train some doctors in prehospital care, Tokaro EMS was disbanded a few years...
Source: JEMS Operations - May 31, 2017 Category: Emergency Medicine Authors: Nnamdi Nwauwa, EMT, CCEMTP, MBBS, MPH, MMSCEM Tags: Ambulances & Vehicle Ops Cardiac Resuscitation Communications Dispatch Source Type: news

Cochrane Response seeks Systematic Reviewer - flexible location
Specifications:  Full Time or Part Time, PermanentSalary:Dependant on Experience,Location:Flexible locationApplication Closing Date: 23 June 2017Cochrane Response is Cochrane ’s evidence consultancy unit, providing a broad range of literature review and evidence synthesis services to international policy makers, guideline developers and research organisations, to support evidence-informed healthcare decision making. We provide tailored evidence synthesis services, resp onding to commissioners’ needs on a project by project basis. We work closely with Cochrane networks to increase Cochrane’s capacity ...
Source: Cochrane News and Events - May 24, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Pegasus unveils new brand identity as it celebrates a year as part of Ashfield
Managing Director, Simon Hackett comments: “Its strength is in its simplicity, and our compelling mission of ‘inspiring healthy decisions’ remains at its heart. It uses strong graphic devices alongside striking campaign imagery to bring to life our personality and creativity, all backed by the strength and experience of Ashfield.” The new brand is just one part of the agency’s continuous evolution. Fixed on its course to inspire healthy decisions through creative integrated communications, Pegasus has built a team of 110 people working with a ‘health first, sector second’ approach...
Source: Ashfield Healthcare News - May 24, 2017 Category: Pharmaceuticals Authors: Sarah Edwards Tags: Ashfield Source Type: news

Dr Saif Abed Talks about the WannaCry Attack
The WannaCry or WannaDecryptor virus was a world-wide phenomenon, but the NHS was badly hit. Dr Saif Abed, a founding partner of the health IT consultancy AbedGraham, says a forensic inquiry should be held into what went wrong; so the NHS can deal with the clinical and patient risk issues it exposed. (Source: eHealth News EU)
Source: eHealth News EU - May 15, 2017 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Ashfield Meetings & Events announces financial results for 2016
Earnings before interest and tax (EBIT) for the period was £5.482m compared to £4.91m in the previous 12-month period, an increase of 11.6%. This is the second year running the agency have demonstrated double-digit EBIT growth. The numbers have been consolidated from accounts covering the company’s operations across Europe, the US and Asia. Commenting on the performance, Nicola Burns (Global Managing Director) said: “We have had a number of new business wins, both in Europe and the US, that has helped achieve a strong set of results. This has included numerous consultancy projects, dedicated client ...
Source: Ashfield Healthcare News - May 9, 2017 Category: Pharmaceuticals Authors: Ewan Jamieson Tags: Ashfield Source Type: news

Stratos PD: What went wrong and what does it mean for medtech?
There has been some conjecture since the once premier consulting firm, Stratos Product Development, shut down last week. Those closest to the company have expressed a deep sadness in the abrupt end of a company that— at least from the outside — represented the pinnacle of what a medical technology consultancy firm could achieve. MDO spoke with Cameron Smith, the CEO and Founder of Seattle-based Product Creation Studio. Smith is a local competitor and one-time employee of Stratos. Smith, who knows many of the employees, shared some insights and laments about the state of product consultancies, particularly those...
Source: Mass Device - May 8, 2017 Category: Medical Equipment Authors: Heather Thompson Tags: Blog contract manufacturing Design Devices Medical Device Business Source Type: news

Advisory Board reports massive jump in income despite tumultuous first quarter
D.C.-based The Advisory Board Co. saw its share price jump Friday after reporting a 90 percent year-over-year increase in first-quarter net income, beating analyst expectations. The improved margins come after the health and education consultancy embarked on a cost-cutting mission, resulting in $11.2 million in restructuring-related charges. Advisory Board also reported a $23.4 million gain from selling Evolent Health stock during the quarter. For the first quarter, Advis ory Board (NASDAQ: ABCO)… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 5, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Advisory Board reports massive jump in income despite tumultuous first quarter
D.C.-based The Advisory Board Co. saw its share price jump Friday after reporting a 90 percent year-over-year increase in first-quarter net income, beating analyst expectations. The improved margins come after the health and education consultancy embarked on a cost-cutting mission, resulting in $11.2 million in restructuring-related charges. Advisory Board also reported a $23.4 million gain from selling Evolent Health stock during the quarter. For the first quarter, Advis ory Board (NASDAQ: ABCO)… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 5, 2017 Category: American Health Authors: Tina Reed Source Type: news

myClin Launches Clinical Works, A ClinOps And Creative Consultancy For...
The Team Behind myClin, The Leading Clinical Trial Knowledge Platform, Today Announced The Launch Of Clinical Works, A New Consultancy Combining Operations, Communications And Creative Services For...(PRWeb May 04, 2017)Read the full story at http://www.prweb.com/releases/2017/05/prweb14298765.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 4, 2017 Category: Pharmaceuticals Source Type: news

Nuventra founder inks deal for new venture that could be worth as much as $49 million
A Research Triangle Park-based virtual drug development company 1st Order Pharmaceuticals (1OP) has inked a deal with Canada ’s Xenon Pharmaceuticals (Nasdaq: XENE) that could be worth as much as $49 million. 1OP was founded in 2013 by Christopher Crean, former North American head of Clinical Pharmacology and Pharmacokinetics at Valeant Pharmaceuticals (NYSE: VRX), and Dr. Geoffrey Banks, founder and CEO of fast-growin g, Durham-based drug development consultancy Nuventra Pharma Sciences. Crean… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 28, 2017 Category: Health Management Authors: Jennifer Henderson Source Type: news

Nuventra founder inks deal for new venture that could be worth as much as $49 million
A Research Triangle Park-based virtual drug development company 1st Order Pharmaceuticals (1OP) has inked a deal with Canada ’s Xenon Pharmaceuticals (Nasdaq: XENE) that could be worth as much as $49 million. 1OP was founded in 2013 by Christopher Crean, former North American head of Clinical Pharmacology and Pharmacokinetics at Valeant Pharmaceuticals (NYSE: VRX), and Dr. Geoffrey Banks, founder and CEO of fast-growin g, Durham-based drug development consultancy Nuventra Pharma Sciences. Crean… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 28, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news